Drug intelligence / Profile preview

Liangxue Tongyu Prescription

Development stage
Preclinical
Lead developer
Nanjing University of Chinese Medicine
Administration
Oral, Nasogastric
01

Overview

Liangxue Tongyu Prescription (LTP), also known as 凉血通瘀方, is a traditional Chinese medicine (TCM) formula used for the treatment of acute intracerebral hemorrhage (AICH). [2, 4, 6] The name translates to "cooling blood and resolving stasis," which reflects its function in TCM theory. The prescription is a complex combination of eight ingredients, including botanicals like Rheum palmatum (Dahuang) and Panax notoginseng (Sanqi), as well as animal-derived components like Bubali Cornu (water buffalo horn) and Pheretima aspergillum (earthworm). [4] Research indicates that its therapeutic effects are multifactorial, involving anti-inflammatory, neuroprotective, and anticoagulant activities. [2] The mechanism is believed to be mediated through multiple pathways, including the regulation of the gut-brain axis, modulation of intestinal microflora, reduction of inflammatory cytokines like TNF-α and IL-1β, and inhibition of the TLR4/NF-κB signaling pathway. [3, 5, 12] Clinical studies have investigated its use as an oral solution to reduce hematoma, alleviate brain edema, and improve neurological function following a stroke. [14]

Other names
凉血通瘀方Liangxue Tongyu Formula
02

Targets

TLR4 (Toll-like receptor 4)IL1B (Interleukin-1 beta)TNFA (Tumor necrosis factor alpha (soluble))IL-6 (Interleukin 6)CCKAR (Cholecystokinin A receptor)NF-κB

Beyond the preview

Go deeper on Liangxue Tongyu Prescription.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Liangxue Tongyu Prescription.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call